Literature DB >> 25239759

Differential proteomic profiling unveils new molecular mechanisms associated with mitochondrial complex III deficiency.

Lorena Marín-Buera1,2, Alberto García-Bartolomé1,2, María Morán1,2, Elia López-Bernardo3,4, Susana Cadenas3,4, Beatriz Hidalgo5, Ricardo Sánchez5, Sara Seneca6, Joaquín Arenas1,2, Miguel A Martín1,2, Cristina Ugalde1,2.   

Abstract

We have analyzed the cellular pathways and metabolic adaptations that take place in primary skin fibroblasts from patients with mutations in BCS1L, a major genetic cause of mitochondrial complex III enzyme deficiency. Mutant fibroblasts exhibited low oxygen consumption rates and intracellular ATP levels, indicating that the main altered molecular event probably is a limited respiration-coupled ATP production through the OXPHOS system. Two-dimensional DIGE and MALDI-TOF/TOF mass spectrometry analyses unambiguously identified 39 proteins whose expression was significantly altered in complex III-deficient fibroblasts. Extensive statistical and cluster analyses revealed a protein profile characteristic for the BCS1L mutant fibroblasts that included alterations in energy metabolism, cell signaling and gene expression regulation, cytoskeleton formation and maintenance, and intracellular stress responses. The physiological validation of the predicted functional adaptations of human cultured fibroblasts to complex III deficiency confirmed the up-regulation of glycolytic enzyme activities and the accumulation of branched-chain among other amino acids, suggesting the activation of anaerobic glycolysis and cellular catabolic states, in particular protein catabolism, together with autophagy as adaptive responses to mitochondrial respiratory chain dysfunction and ATP deficiency. Our data point to an overall metabolic and genetic reprogramming that could contribute to explain the clinical manifestations of complex III deficiency in patients. BIOLOGICAL SIGNIFICANCE: Despite considerable knowledge about their genetic origins, the pathophysiological mechanisms that contribute to the clinical manifestations of mitochondrial disorders remain poorly understood. We have investigated the molecular pathways and metabolic adaptations that take place in primary skin fibroblasts from patients with mutations in the BCS1L gene, a primary cause of mitochondrial complex III enzyme deficiency. Two-dimensional DIGE together with MALDI-TOF/TOF mass spectrometry and physiological validation analyses revealed a significant metabolic and genetic reprogramming as an adaptive response to mitochondrial respiratory chain dysfunction. Our data provide information about specific protein targets that regulate the transmitochondrial functional responses to complex III deficiency, thereby opening new doors for future research.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2D-DIGE; BCS1L; Complex III deficiency; Mitochondria; OXPHOS system; Respiratory chain

Mesh:

Substances:

Year:  2014        PMID: 25239759      PMCID: PMC4259860          DOI: 10.1016/j.jprot.2014.09.007

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  64 in total

1.  BCS1L gene mutation presenting with GRACILE-like syndrome and complex III deficiency.

Authors:  Adrienne M Lynn; Richard I King; Richard J Mackay; Chris M Florkowski; Callum J Wilson
Journal:  Ann Clin Biochem       Date:  2012-01-25       Impact factor: 2.057

2.  The structure of the GTPase-activating domain from p50rhoGAP.

Authors:  T Barrett; B Xiao; E J Dodson; G Dodson; S B Ludbrook; K Nurmahomed; S J Gamblin; A Musacchio; S J Smerdon; J F Eccleston
Journal:  Nature       Date:  1997-01-30       Impact factor: 49.962

Review 3.  Multiple roles of annexin A2 in post-transcriptional regulation of gene expression.

Authors:  Anni Vedeler; Hanne Hollås; Ann Kari Grindheim; Aase M Raddum
Journal:  Curr Protein Pept Sci       Date:  2012-06       Impact factor: 3.272

4.  Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein.

Authors:  H L Yin; T P Stossel
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

5.  A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure.

Authors:  P de Lonlay; I Valnot; A Barrientos; M Gorbatyuk; A Tzagoloff; J W Taanman; E Benayoun; D Chrétien; N Kadhom; A Lombès; H O de Baulny; P Niaudet; A Munnich; P Rustin; A Rötig
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

6.  A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis.

Authors:  Sandrine Haut; Michèle Brivet; Guy Touati; Pierre Rustin; Sophie Lebon; Angela Garcia-Cazorla; Jean Marie Saudubray; Audrey Boutron; Alain Legrand; Abdelhamid Slama
Journal:  Hum Genet       Date:  2003-04-23       Impact factor: 4.132

7.  Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species.

Authors:  Anatoly A Starkov; Gary Fiskum; Christos Chinopoulos; Beverly J Lorenzo; Susan E Browne; Mulchand S Patel; M Flint Beal
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

8.  Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation.

Authors:  Noriko Miyake; Shoji Yano; Chika Sakai; Hideyuki Hatakeyama; Yuichi Matsushima; Masaaki Shiina; Yoriko Watanabe; James Bartley; Jose E Abdenur; Raymond Y Wang; Richard Chang; Yoshinori Tsurusaki; Hiroshi Doi; Mitsuko Nakashima; Hirotomo Saitsu; Kazuhiro Ogata; Yu-Ichi Goto; Naomichi Matsumoto
Journal:  Hum Mutat       Date:  2013-01-29       Impact factor: 4.878

9.  Infantile mitochondrial encephalomyopathy with unusual phenotype caused by a novel BCS1L mutation in an isolated complex III-deficient patient.

Authors:  Alberto Blázquez; Mari Carmen Gil-Borlado; María Morán; Alfonso Verdú; María Rosario Cazorla-Calleja; Miguel A Martín; Joaquín Arenas; Cristina Ugalde
Journal:  Neuromuscul Disord       Date:  2009-01-21       Impact factor: 4.296

10.  Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53.

Authors:  Tuck Seng Wong; Sridharan Rajagopalan; Fiona M Townsley; Stefan M Freund; Miriana Petrovich; David Loakes; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2008-12-09       Impact factor: 16.971

View more
  11 in total

1.  A genome-wide analysis of cardiac lesions of pigs that die during transport: Is heart failure of in-transit-loss pigs associated with a heritable cardiomyopathy?

Authors:  Katherine Zurbrigg; Francesca Bertolini; Muhammed Walugembe; Toni van Dreumel; David Alves; Robert Friendship; Terri L O'Sullivan; Max F Rothschild
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

2.  Respiratory chain enzyme deficiency induces mitochondrial location of actin-binding gelsolin to modulate the oligomerization of VDAC complexes and cell survival.

Authors:  Alberto García-Bartolomé; Ana Peñas; Lorena Marín-Buera; Teresa Lobo-Jarne; Rafael Pérez-Pérez; María Morán; Joaquín Arenas; Miguel A Martín; Cristina Ugalde
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

3.  A novel mutation in BCS1L associated with deafness, tubulopathy, growth retardation and microcephaly.

Authors:  C B Jackson; M F Bauer; A Schaller; U Kotzaeridou; A Ferrarini; D Hahn; H Chehade; F Barbey; C Tran; S Gallati; A Haeberli; S Eggimann; L Bonafé; J-M Nuoffer
Journal:  Eur J Pediatr       Date:  2015-11-13       Impact factor: 3.183

4.  Altered Expression Ratio of Actin-Binding Gelsolin Isoforms Is a Novel Hallmark of Mitochondrial OXPHOS Dysfunction.

Authors:  Alberto García-Bartolomé; Ana Peñas; María Illescas; Verónica Bermejo; Sandra López-Calcerrada; Rafael Pérez-Pérez; Lorena Marín-Buera; Cristina Domínguez-González; Joaquín Arenas; Miguel A Martín; Cristina Ugalde
Journal:  Cells       Date:  2020-08-19       Impact factor: 6.600

5.  Exploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction.

Authors:  Roberta Peruzzo; Samantha Corrà; Roberto Costa; Michele Brischigliaro; Tatiana Varanita; Lucia Biasutto; Chiara Rampazzo; Daniele Ghezzi; Luigi Leanza; Mario Zoratti; Massimo Zeviani; Cristiano De Pittà; Carlo Viscomi; Rodolfo Costa; Ildikò Szabò
Journal:  Nat Commun       Date:  2021-04-08       Impact factor: 17.694

6.  Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.

Authors:  Ana Peñas; Miguel Fernández-De la Torre; Sara Laine-Menéndez; David Lora; María Illescas; Alberto García-Bartolomé; Montserrat Morales-Conejo; Joaquín Arenas; Miguel A Martín; María Morán; Cristina Domínguez-González; Cristina Ugalde
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

7.  Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts.

Authors:  Maria Peiris-Pagès; Duncan L Smith; Balázs Győrffy; Federica Sotgia; Michael P Lisanti
Journal:  Aging (Albany NY)       Date:  2015-10       Impact factor: 5.682

8.  The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression.

Authors:  Katarzyna Głombik; Aneta Stachowicz; Rafał Olszanecki; Joanna Ślusarczyk; Ewa Trojan; Władysław Lasoń; Marta Kubera; Bogusława Budziszewska; Michael Spedding; Agnieszka Basta-Kaim
Journal:  Mol Neurobiol       Date:  2016-03-02       Impact factor: 5.590

9.  Caspase-2 deficiency enhances whole-body carbohydrate utilisation and prevents high-fat diet-induced obesity.

Authors:  Claire H Wilson; Andrej Nikolic; Stephen J Kentish; Marianne Keller; George Hatzinikolas; Loretta Dorstyn; Amanda J Page; Sharad Kumar
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

10.  Optimal Estimate for Energy Requirements in Adult Patients With the m.3243A>G Mutation in Mitochondrial DNA.

Authors:  Heidi E E Zweers; Mirian C H Janssen; Geert J A Wanten
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-08-01       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.